IO Biotech Files Definitive Proxy Statement
Ticker: IOBT · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1865494
| Field | Detail |
|---|---|
| Company | Io Biotech, Inc. (IOBT) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
IO Biotech filed its proxy statement for the June 5th meeting - shareholders vote soon!
AI Summary
IO Biotech, Inc. filed its definitive proxy statement on April 25, 2025, for its annual meeting on June 5, 2025. The filing covers the fiscal year ending December 31, 2024. The company is based in Copenhagen, Denmark, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides shareholders with essential information regarding the upcoming annual meeting, including details on voting, director nominations, and company performance, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine filing of a definitive proxy statement, not indicating any immediate financial or operational risks.
Key Numbers
- 20250425 — Filing Date (Date the definitive proxy statement was filed.)
- 20250605 — Meeting Date (Date of the shareholder meeting for which the proxy statement is issued.)
Key Players & Entities
- IO Biotech, Inc. (company) — Registrant
- 0000950170-25-058699 (filing_id) — Accession Number
- 20250425 (date) — Filing Date
- 20250605 (date) — Meeting Date
- 2024-12-31 (date) — Fiscal Year End
- Copenhagen (location) — Company Headquarters
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information required in a proxy statement for the annual meeting of IO Biotech, Inc.
When is the shareholder meeting scheduled?
The shareholder meeting is scheduled for June 5, 2025.
What is the fiscal year end for IO Biotech, Inc. as stated in the filing?
The fiscal year end for IO Biotech, Inc. is December 31.
Where is IO Biotech, Inc. located?
IO Biotech, Inc. is located in Copenhagen, Denmark.
What is the filing date of this definitive proxy statement?
The definitive proxy statement was filed on April 25, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding IO Biotech, Inc. (IOBT).